arrow_back Back Filing freshness 10-K FY 2026 SEC EDGAR

MCKESSON CORP

MCK
$869.27 ▼ -1.46 (-0.17%) at close
Healthcare ·Wholesale-Drugs, Proprietaries & Druggists' Sundries ·USWholesale-Drugs, Proprietaries & Druggists' Sundries
20 Visible periods
34 Metrics
Peer-ranked Benchmarks
Price Chart
42
Health
Weak
Moderately Bearish
auto_awesome

Analytical Summary

MCKESSON CORP faces fundamental challenges with weakness in Return on Common Equity (%). Investors should exercise caution and monitor for improvement in key metrics.

Market Cap $107.4B
Dividend Yield 0.36%
Revenue Growth 12.4%
Op. Margin 1.5%
ROIC 117.3%
FCF / Share $46.27
Trailing P/E 22.6x
Price / Book
FCF Yield 5.3%
Debt / Equity -3.00
info Valuation on last close. End-of-day price, Aug 7, 2026.

20-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$403.43B
↑ +12.4%
Net Income Profit after all expenses
$4.76B
↑ +44.5%
Operating Margin Operating profit as % of sales
1.5%
↑ +25.0% 34th
FCF / Share Free cash flow per share
$46.27
↑ +6.3%
Long-Term Debt Long-term obligations
$6.53B
↑ +15.4%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
31
Returns
1
Financial Health
95
Cash Quality
66

Dividend History

Dividend / share · sourced from SEC filings
$3.17 Latest / share
+15.3% YoY
+11.5% 12-yr CAGR

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 20 years · 74 quarters